Adrenal Crisis Mimicking COVID-19 Encephalopathy in a Teenager with Craniopharyngioma
Abstract
:1. Introduction
2. Case Presentation
3. Discussion
3.1. COVID-19 in Children with Cancer and Brain Tumor
3.2. Adrenal Insufficiency in COVID-19 Patients
3.3. Neurological Manifestation of COVID-19 and the Current Management
3.4. Long COVID
3.5. Limitations
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Dawood, F.S.; Porucznik, C.A.; Veguilla, V.; Stanford, J.B.; Duque, J.; Rolfes, M.A.; Dixon, A.; Thind, P.; Hacker, E.; Castro, M.J.E.; et al. Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York. JAMA Pediatr. 2022, 176, 59–67. [Google Scholar] [CrossRef] [PubMed]
- Abdel-Mannan, O.; Eyre, M.; Löbel, U.; Bamford, A.; Eltze, C.; Hameed, B.; Hemingway, C.; Hacohen, Y. Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. JAMA Neurol. 2020, 77, 1440–1445. [Google Scholar] [CrossRef] [PubMed]
- Aljomah, L.; Almedlej, S.; Baarmah, D.; Altwaijri, W.; Alrumayyan, A.; Alrifai, M.T.; Almuqbil, M.; Alshalaan, M. Pediatrics COVID-19 and neurological manifestations: Single tertiary centre experience. eNeurologicalSci 2021, 24, 100355. [Google Scholar] [CrossRef] [PubMed]
- Gürkas, E.; Dünya, B.; Köken, Ö.Y.; Demirdağ, T.; Yilmaz, D.; Özyürek, H.; Kurt, A. Neurologic manifestations of COVID 19 in children: Prospective study in a single center. Ann. Indian Acad. Neurol. 2021, 24, 891–895. [Google Scholar] [CrossRef] [PubMed]
- Panda, P.K.; Sharawat, I.K.; Panda, P.; Natarajan, V.; Bhakat, R.; Dawman, L. Neurological Complications of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis. J. Trop. Pediatr. 2021, 67, fmaa070. [Google Scholar] [CrossRef] [PubMed]
- Fink, E.L.; Robertson, C.L.; Wainwright, M.S.; Roa, J.D.; Lovett, M.E.; Stulce, C.; Yacoub, M.; Potera, R.M.; Zivick, E.; Holloway, A.; et al. Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C. Pediatr. Neurol. 2022, 128, 33–44. [Google Scholar] [CrossRef]
- Husebye, E.S.; Pearce, S.H.; Krone, N.P.; Kämpe, O. Adrenal insufficiency. Lancet 2021, 397, 613–629. [Google Scholar] [CrossRef]
- Patti, G.; Guzzeti, C.; Di Iorgi, N.; Allegri, A.E.M.; Napoli, F.; Loche, S.; Maghnie, M. Central adrenal insufficiency in children and adolescents. Best Pract. Res. Clin. Endocrinol. Metab. 2018, 32, 425–444. [Google Scholar] [CrossRef]
- Sundberg, E.; Georgantzi, K.; Langenskiöld, C.; Król, L.; Nilsson, F.; Vogt, H.; Palle, J.; Ek, T.; Nilsson, A. Low numbers of COVID-19 in Swedish pediatric oncology patients during the first pandemic year despite an open society. Pediatr. Blood Cancer 2022, e29750. [Google Scholar] [CrossRef]
- Bisogno, G.; Provenzi, M.; Zama, D.; Tondo, A.; Meazza, C.; Colombini, A.; Galaverna, F.; Compagno, F.; Carraro, F.; De Santis, R.; et al. Clinical Characteristics and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Italian Pediatric Oncology Patients: A Study from the Infectious Diseases Working Group of the Associazione Italiana di Oncologia e Ematologia Pediatrica. J. Pediatr. Infect. Dis. Soc. 2020, 9, 530–534. [Google Scholar] [CrossRef]
- Madhusoodhan, P.P.; Pierro, J.; Musante, J.; Kothari, P.; Gampel, B.; Appel, B.; Levy, A.; Tal, A.; Hogan, L.; Sharma, A.; et al. Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience. Pediatr. Blood Cancer 2021, 68, e28843. [Google Scholar] [CrossRef]
- Ronsley, R.; Bouffet, E. COVID-19 in pediatric cancer: Where are the brain tumors? Neuro Oncol. 2021, 23, 1977–1979. [Google Scholar] [CrossRef] [PubMed]
- Gaudino, R.; Orlandi, V.; Cavarzere, P.; Chinello, M.; Antoniazzi, F.; Cesaro, S.; Piacentini, G. Case Report: SARS-CoV-2 Infection in a Child with Suprasellar Tumor and Hypothalamic-Pituitary Failure. Front. Endocrinol. 2021, 12, 596654. [Google Scholar] [CrossRef] [PubMed]
- Flokas, M.E.; Bustamante, V.H.; Kanakatti Shankar, R. New onset Primary Adrenal Insufficiency and Autoimmune Hypothyroidism in a Pediatric Patient presenting with MIS-C. Horm. Res. Paediatr. 2022. [Google Scholar] [CrossRef] [PubMed]
- Bhattarai, P.; Allen, H.; Aggarwal, A.; Madden, D.; Dalton, K. Unmasking of Addison’s disease in COVID-19. SAGE Open Med Case Rep. 2021, 9, 2050313x211027758. [Google Scholar] [CrossRef]
- Cheraghali, F.; Tahamtan, A.; Hosseini, S.A.; Gharib, M.H.; Moradi, A.; Razavi Nikoo, H.; Tabarraei, A. Case Report: Detection of SARS-CoV-2 From Cerebrospinal Fluid in a 34-Month-Old Child with Encephalitis. Front. Pediatr. 2021, 9, 565778. [Google Scholar] [CrossRef]
- Salman, M.A.; Mallah, S.I.; Khalid, W.; Moran, L.R.; Abousedu, Y.A.; Jassim, G.A. Characteristics of Patients with SARS-CoV-2 Positive Cerebrospinal Fluid: A Systematic Review. Int. J. Gen. Med. 2021, 14, 10385–10395. [Google Scholar] [CrossRef]
- Bhavsar, S.M.; Agarwal, S.; Lewis, R.; Ganta, A.; Roshchina, Y.S.; Clouser, K.N.; Baer, A.Z.; Gliksman, F.; Piwoz, J.A. COVID-19 Infection Associated with Encephalitis in an Adolescent. Neurol. Clin. Pract. 2021, 11, e189–e192. [Google Scholar] [CrossRef]
- Krishnan, P.; Glenn, O.A.; Samuel, M.C.; Sheriff, H.; Foster-Barber, A.; Sejvar, J.J.; Roy-Burman, A.; Wadford, D.A.; Preas, C.P.; Tureen, J.H.; et al. Acute Fulminant Cerebral Edema: A Newly Recognized Phenotype in Children with Suspected Encephalitis. J. Pediatric Infect. Dis. Soc. 2021, 10, 289–294. [Google Scholar] [CrossRef]
- Lan, S.-Y.; Lin, J.-J.; Hsia, S.-H.; Wang, H.-S.; Chiu, C.-H.; Lin, K.-L. Analysis of Fulminant Cerebral Edema in Acute Pediatric Encephalitis. Pediatr. Neonatol. 2016, 57, 402–407. [Google Scholar] [CrossRef]
- Ninan, S.; Thompson, P.; Gershon, T.; Ford, N.; Mills, W.; Jewells, V.; Thorne, L.; Saunders, K.; Bouldin, T.; Smedberg, J.R.; et al. Fatal Pediatric COVID-19 Case with Seizures and Fulminant Cerebral Edema. Child Neurol. Open 2021, 8, 2329048x211022532. [Google Scholar] [CrossRef] [PubMed]
- Chen, T.-H. Neurological involvement associated with COVID-19 infection in children. J. Neurol. Sci. 2020, 418, 117096. [Google Scholar] [CrossRef] [PubMed]
- Zimmermann, P.; Pittet, L.F.; Curtis, N. How Common is Long COVID in Children and Adolescents? Pediatr. Infect. Dis. J. 2021, 40, e482–e487. [Google Scholar] [CrossRef]
- Ludvigsson, J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021, 110, 914–921. [Google Scholar] [CrossRef] [PubMed]
- Asadi-Pooya, A.A.; Nemati, H.; Shahisavandi, M.; Akbari, A.; Emami, A.; Lotfi, M.; Rostamihosseinkhani, M.; Barzegar, Z.; Kabiri, M.; Zeraatpisheh, Z.; et al. Long COVID in children and adolescents. World J. Pediatr. 2021, 17, 495–499. [Google Scholar] [CrossRef] [PubMed]
Test | Our Case | Normal Range |
---|---|---|
White blood cell | 6700/uL | 4000–11,000/uL |
Hemoglobin | 12.8 g/dL | 13–17 g/dL |
Platelet | 211 × 103/uL | 130–400 × 103/uL |
Neutrophil | 59.3% | 40–74% |
Lymphocyte | 21.1% | 19–48% |
Monocyte | 17.6% | 2–12% |
Eosinophils | 1.5% | 0–7% |
Basophils | 0.5% | 0–2% |
Prothrombin time | 15.9 s | 11–15 s |
aPTT | 53.9 s | 32–45 s |
Fibrinogen | 350 mg/dL | 200–400 mg/dL |
D-dimer | 0.73 ug/mL | <0.5 ug/mL |
FDP | <4 ug/mL | <5 ug/mL |
C-reactive protein | 2.01 mg/dL | <0.5 mg/dL |
Procalcitonin | 0.51 ng/mL | <0.046 ng/ml |
Interleukin-6 | 145.3 pg/mL | <7 pg/mL |
Blood urea nitrogen | 13 mg/dL | 6–20 mg/dL |
Creatinine | 0.8 mg/dL | 0.7–1.2 mg/dL |
AST | 88 U/L | <40 U/L |
ALT | 49 U/L | <41 U/L |
Direct bilirubin | 0.4 mg/dL | 0–0.3 mg/dL |
Total bilirubin | 0.9 mg/dL | 0–1.2 mg/dL |
Creatinine kinase | 44 U/L | 20–200 U/L |
Creatinine kinase-MB | 12 U/L | <25 U/L |
Troponin T | 0.006 ng/mL | 0–0.014 ng/mL |
Glucose | 149 mg/dL | 80–140 mg/dL |
Ammonia | 28 ug/dL | 27–102 ug/dL |
Lactate | 6.1 mg/dL | 4.5–19.8 mg/dL |
Na | 133 mEg/L | 136–145 mEg/L |
K | 3.4 mEg/L | 3.5–5.1 mEg/L |
Ca | 8.6 mg/dL | 8.6–10.2 mg/dL |
Mg | 1.9 mg/dL | 1.6–2.6 mg/dL |
P | 4.7 mg/dL | 2.7–4.5 mg/dL |
Cortisol (PM) * | 0.05 ug/dL | 7–10 AM: 6.2–19.4 ug/dL 4–8 PM: 2.3–11.9 ug/dL |
ACTH * | 10.3 pg/mL | 7.9–47.1 pg/mL |
T3 * | 152 ng/dL | 80–200 ng/dL |
Free T4 * | 1.7 ng/dL | 0.93–1.7 ng/dL |
TSH * | <0.01 ulU/mL | 0.27–4.2 ulU/mL |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chien, T.-C.; Chien, M.-M.; Liu, T.-L.; Chang, H.; Tsai, M.-L.; Tseng, S.-H.; Ho, W.-L.; Su, Y.-Y.; Lin, H.-C.; Lu, J.-H.; et al. Adrenal Crisis Mimicking COVID-19 Encephalopathy in a Teenager with Craniopharyngioma. Children 2022, 9, 1238. https://doi.org/10.3390/children9081238
Chien T-C, Chien M-M, Liu T-L, Chang H, Tsai M-L, Tseng S-H, Ho W-L, Su Y-Y, Lin H-C, Lu J-H, et al. Adrenal Crisis Mimicking COVID-19 Encephalopathy in a Teenager with Craniopharyngioma. Children. 2022; 9(8):1238. https://doi.org/10.3390/children9081238
Chicago/Turabian StyleChien, Tzu-Chien, Mu-Ming Chien, Tsai-Ling Liu, Hsi Chang, Min-Lan Tsai, Sung-Hui Tseng, Wan-Ling Ho, Yi-Yu Su, Hsiu-Chen Lin, Jen-Her Lu, and et al. 2022. "Adrenal Crisis Mimicking COVID-19 Encephalopathy in a Teenager with Craniopharyngioma" Children 9, no. 8: 1238. https://doi.org/10.3390/children9081238